Comments

OnKure Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does OnKure Therapeutics (OKUR) operate in?

OnKure Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

OKURNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$3.13

-0.76-19.54%

At close: -

$4.26

1.1336.10%

After Hours: Apr 1, 4:02 PM EDT

OnKure Therapeutics (OKUR) Forecast

News Earnings OnKure Therapeutics (OKUR) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

OnKure Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:OKUR | Benzinga

Explore OnKure Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for OKUR.

Open	$3.68
Close	$3.13
Volume / Avg.	309.49K / 66.36K
Day Range	$3.05 - $3.68
52 Wk Range	3.82 - 20.00
Market Cap	$57.24M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	15
Short Interest	-
Days to Cover	27.97

Recent News

Gilead Sciences To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Tuesday

Avi Kapoor

Recently Listed Cancer Firm OnKure's Innovative Approach to Breast Cancer Treatment Sparks Analyst Enthusiasm

OnKure Therapeutics has garnered attention following its merger with Reneo Pharmaceuticals and a $65 million private placement. Oppenheimer initiated coverage with an Outperform rating, highlighting the potential of OKI-219 in targeting breast cancer mutations.

Vandana Singh

This Builders FirstSource Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Dec 24

Jan

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$3.68
Close	$3.13
Volume / Avg.	309.49K / 66.36K
Day Range	$3.05 - $3.68
52 Wk Range	3.82 - 20.00
Market Cap	$57.24M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	15
Short Interest	-
Days to Cover	27.97

About OnKure Therapeutics Inc.

Sector

Health Care

Industry

Biotechnology

OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and dev...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy OnKure Therapeutics (OKUR) stock?

You can purchase shares of OnKure Therapeutics (NASDAQ:OKUR) through any online brokerage.

View our list of the best stock brokerages

Who are OnKure Therapeutics (OKUR) competitors?

Other companies in OnKure Therapeutics’s space includes: Serina Therapeutics (AMEX:SER), Cabaletta Bio (NASDAQ:CABA), bluebird bio (NASDAQ:BLUE), Gain Therapeutics (NASDAQ:GANX) and Inozyme Pharma (NASDAQ:INZY).

What is the forecast, or price target, for OnKure Therapeutics (OKUR) stock?

OnKure Therapeutics has a consensus price target of $32.25.

What is the current price for OnKure Therapeutics (OKUR)?

The stock price for OnKure Therapeutics (NASDAQ: OKUR) is $4.26 last updated April 1, 2025 at 4:02 PM EDT.

Does OnKure Therapeutics (OKUR) pay a dividend?

There are no upcoming dividends for OnKure Therapeutics.

When is OnKure Therapeutics (NASDAQ:OKUR) reporting earnings?

OnKure Therapeutics’s Q1 earnings are confirmed for Wednesday, May 14, 2025.

Is OnKure Therapeutics (OKUR) going to split?

There is no upcoming split for OnKure Therapeutics.

What sector and industry does OnKure Therapeutics (OKUR) operate in?

OnKure Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.